We sincerely apologize for the inconvenience of updating the authorship. Farid Menaa was not included as an author in the published article [1]. The corrected Author Contributions Statement appears here. The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.
Author Contributions
Conceptualization, B.U.; and N.Z.; methodology, M.B.K.N.; software, S.S.; and A.B.; validation, G.S. and W.U.-N.; formal analysis, F.M.; N.J.; investigation, N.Z.; and F.M.; resources, S.S.; and A.B.; data interpretation, N.Z.; and F.M.; writing—original draft preparation, N.Z.; review and editing, B.U.; and F.M.; visualization, M.B.K.N.; and W.U.-N.; supervision, B.U.; project administration, M.B.K.N. All authors have read and agreed to the published version of the manuscript.
Reference
- Zafar, N.; Uzair, B.; Niazi, M.B.K.; Samin, G.; Bano, A.; Jamil, N.; Waqar-Un-Nisa; Sajjad, S.; Menaa, F. Synthesis and Characterization of Potent and Safe Ciprofloxacin-Loaded Ag/TiO2/CS Nanohybrid against Mastitis Causing E. coli. Crystals 2021, 11, 319. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).